Company Email Format Management

InDex Pharmaceuticals AB

Pharmaceutical Manufacturing Solna, Stockholms Län, Se 10 employees INDEX

Employees: 10

indexpharma.com LinkedIn Crunchbase

InDex Pharmaceuticals AB Overview

Headquarters: Solna, Stockholms Län, Se
Phone Number: Available in AeroLeads
Website: indexpharma.com
Industry: Pharmaceutical Manufacturing
Employees: 10
Founded: 2000
Stock Symbol: INDEX
Funding: 201.9K
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About InDex Pharmaceuticals AB

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company’s lead asset is the drug candidate cobitolimod, which is being evaluated in the phase III study CONCLUDE as a novel treatment of moderate to severe ulcerative colitis – a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in the treatment of various immunological diseases. InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.